Spire Wealth Management Teva Pharmaceutical Industries LTD Transaction History

Spire Wealth Management

  • $2.95 Billion
  • Q3 2024

A detailed history of Spire Wealth Management transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Spire Wealth Management holds 4,994 shares of TEVA stock, worth $104,274. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,994
Previous 5,294 5.67%
Holding current value
$104,274
Previous $86,000 3.49%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$15.81 - $18.96 $4,743 - $5,688
-300 Reduced 5.67%
4,994 $89,000
Q2 2024

Jul 31, 2024
SELL
$12.78 - $17.4 $4,728 - $6,437
-370 Reduced 6.53%
5,294 $86,000
Q4 2023

Feb 06, 2024
BUY
$8.12 - $10.63 $649 - $850
80 Added 1.43%
5,664 $59,000
Q2 2023

Aug 09, 2023
BUY
$7.2 - $9.47 $9,900 - $13,021
1,375 Added 32.67%
5,584 $42,000
Q1 2023

May 09, 2023
BUY
$8.36 - $11.37 $11,704 - $15,917
1,400 Added 49.84%
4,209 $37,000
Q4 2022

Feb 03, 2023
SELL
$7.95 - $9.48 $16,361 - $19,509
-2,058 Reduced 42.28%
2,809 $26,000
Q3 2022

Nov 07, 2022
SELL
$6.86 - $11.95 $17,150 - $29,875
-2,500 Reduced 33.94%
4,867 $39,000
Q2 2022

Jul 22, 2022
SELL
$7.38 - $10.4 $44,058 - $62,088
-5,970 Reduced 44.76%
7,367 $55,000
Q1 2022

Apr 18, 2022
SELL
$7.33 - $9.39 $16,712 - $21,409
-2,280 Reduced 14.6%
13,337 $125,000
Q4 2021

Jan 14, 2022
SELL
$7.9 - $10.19 $1,050 - $1,355
-133 Reduced 0.84%
15,617 $125,000
Q3 2021

Oct 22, 2021
BUY
$8.38 - $10.18 $502 - $610
60 Added 0.38%
15,750 $153,000
Q2 2021

Jul 26, 2021
SELL
$9.9 - $11.56 $55,657 - $64,990
-5,622 Reduced 26.38%
15,690 $155,000
Q1 2021

May 21, 2021
BUY
$10.34 - $12.81 $220,366 - $273,006
21,312 New
21,312 $246,000

Others Institutions Holding TEVA

# of Institutions
626
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $23.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email